BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21907168)

  • 1. A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Nahon P; Sutton A; Rufat P; Charnaux N; Mansouri A; Moreau R; Ganne-Carrié N; Grando-Lemaire V; N'Kontchou G; Trinchet JC; Pessayre D; Beaugrand M
    J Hepatol; 2012 Feb; 56(2):426-32. PubMed ID: 21907168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.
    Nahon P; Sutton A; Rufat P; Ziol M; Akouche H; Laguillier C; Charnaux N; Ganne-Carrié N; Grando-Lemaire V; N'Kontchou G; Trinchet JC; Gattegno L; Pessayre D; Beaugrand M
    Hepatology; 2009 Nov; 50(5):1484-93. PubMed ID: 19731237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Catalase and Glutathione Peroxidase 1 Polymorphisms with Chronic Hepatitis C Outcome.
    Sousa VC; Carmo RF; Vasconcelos LR; Aroucha DC; Pereira LM; Moura P; Cavalcanti MS
    Ann Hum Genet; 2016 May; 80(3):145-53. PubMed ID: 26990426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do genetic variations in antioxidant enzymes influence the course of hereditary hemochromatosis?
    Nahon P; Sutton A; Pessayre D; Rufat P; Charnaux N; Trinchet JC; Beaugrand M; Deugnier Y
    Antioxid Redox Signal; 2011 Jul; 15(1):31-8. PubMed ID: 20673159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
    Charni F; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Trinchet JC; Beaugrand M; Charnaux N; Nahon P
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in antioxidant defence genes and susceptibility to hepatocellular carcinoma in a Moroccan population.
    Ezzikouri S; El Feydi AE; Afifi R; Benazzouz M; Hassar M; Pineau P; Benjelloun S
    Free Radic Res; 2010 Feb; 44(2):208-16. PubMed ID: 19929244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis.
    Sutton A; Nahon P; Pessayre D; Rufat P; Poiré A; Ziol M; Vidaud D; Barget N; Ganne-Carrié N; Charnaux N; Trinchet JC; Gattegno L; Beaugrand M
    Cancer Res; 2006 Mar; 66(5):2844-52. PubMed ID: 16510607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in antioxidant enzyme genes and susceptibility to hepatocellular carcinoma in Chinese population: a case-control study.
    Su S; He K; Li J; Wu J; Zhang M; Feng C; Xia X; Li B
    Tumour Biol; 2015 Jun; 36(6):4627-32. PubMed ID: 25894370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study.
    Yen YH; Tsai MC; Wu CK; Chang KC; Hung CH; Chiu KW; Lu SN; Wang JH; Chen CH; Kee KM; Kuo YH; Tseng PL; Lin MT; Huang CM; Lin JT; Hu TH
    J Formos Med Assoc; 2018 Sep; 117(9):833-840. PubMed ID: 29089161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.
    Guyot E; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Beaugrand M; Charnaux N; Trinchet JC; Nahon P
    J Hepatol; 2013 Feb; 58(2):312-8. PubMed ID: 23069476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloperoxidase gene polymorphism predicts fibrosis severity in women with hepatitis C.
    do Carmo RF; Vasconcelos LR; Mendonça TF; de Mendonça Cavalcanti Mdo S; Pereira LM; Moura P
    Hum Immunol; 2014 Aug; 75(8):766-70. PubMed ID: 24882572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations of three important antioxidative enzymes SOD2, CAT, and GPX1 in nonalcoholic steatohepatitis.
    Huang YS; Chang TE; Perng CL; Huang YH
    J Chin Med Assoc; 2021 Jan; 84(1):14-18. PubMed ID: 33009206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphic variations in manganese superoxide dismutase (MnSOD), glutathione peroxidase-1 (GPX1), and catalase (CAT) contribute to elevated plasma triglyceride levels in Chinese patients with type 2 diabetes or diabetic cardiovascular disease.
    Chen H; Yu M; Li M; Zhao R; Zhu Q; Zhou W; Lu M; Lu Y; Zheng T; Jiang J; Zhao W; Xiang K; Jia W; Liu L
    Mol Cell Biochem; 2012 Apr; 363(1-2):85-91. PubMed ID: 22167619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 593C>T GPx1 SNP alone and in synergy with 47C>T SOD2 SNP on the outcome of critically ill patients.
    Majolo F; Oliveira Paludo FJ; Ponzoni A; Graebin P; Dias FS; Alho CS
    Cytokine; 2015 Feb; 71(2):312-7. PubMed ID: 25497738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of superoxide dismutases, catalase, and glutathione peroxidase in age-related cataract.
    Zhang Y; Zhang L; Sun D; Li Z; Wang L; Liu P
    Mol Vis; 2011; 17():2325-32. PubMed ID: 21921984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment.
    Huang CF; Huang CY; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML
    EBioMedicine; 2017 Feb; 15():81-89. PubMed ID: 27998720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.
    Nischalke HD; Berger C; Luda C; Berg T; Müller T; Grünhage F; Lammert F; Coenen M; Krämer B; Körner C; Vidovic N; Oldenburg J; Nattermann J; Sauerbruch T; Spengler U
    PLoS One; 2011; 6(11):e27087. PubMed ID: 22087248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CAT-262 C>T, MnSOD Ala16Val, GPX1 Pro198Leu Polymorphisms Related to Oxidative Stress and the Presence of Gastric Lesions.
    Negovan A; Iancu M; Tripon F; Crauciuc A; Mocan S; Bănescu C
    J Gastrointestin Liver Dis; 2018 Dec; 27(4):371-378. PubMed ID: 30574618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.